Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects.
Adrenomedullin is a novel hypotensive peptide, newly discovered in pheochromocytoma. Because immunoreactive adrenomedullin is present in human plasma, adrenomedullin may play a role in regulating blood pressure. A recent report showed that human adrenomedullin mRNA is expressed not only in pheochromocytoma but also in the normal adrenal medulla, kidney, lung, and ventricle. However, whether or not these organs actually release adrenomedullin into the circulation remains unknown. To investigate the sites of production and degradation of adrenomedullin in human subjects, we obtained blood samples from various sites and measured immunoreactive adrenomedullin concentrations. In study 1, blood samples were obtained from the infrarenal inferior vena cava, suprarenal inferior vena cava, superior vena cava, right atrium, right ventricle, pulmonary artery, pulmonary capillary, left ventricle, and aorta during cardiac catheterization in 15 patients with ischemic heart disease (67 +/- 10 years). In study 2, blood samples were taken from the infrarenal inferior vena cava, suprarenal inferior vena cava, right and left renal veins, and left adrenal vein in 5 hypertensive patients (42 +/- 14 years) suspected of having renovascular hypertension. In study 3, peripheral venous blood samples were obtained in 2 patients (males, 45 and 36 years old) with pheochromocytoma at rest and during hypertensive attacks. Plasma adrenomedullin concentrations were measured by a newly developed radioimmunoassay. In study 1, there were no significant differences in plasma adrenomedullin concentrations in various sites of the right-side circulation. There was no step-up of plasma adrenomedullin levels in the coronary sinus. However, the plasma concentration of adrenomedullin in aorta was slightly but significantly lower than in pulmonary artery.(ABSTRACT TRUNCATED AT 250 WORDS)
Division of Hypertension and Nephrology, National Cardiovascular Center, Osaka, Japan.
T
T
Nishikimi
K
K
Kitamura
Y
Y
Saito
K
K
Shimada
T
T
Ishimitsu
M
M
Takamiya
K
K
Kangawa
H
H
Matsuo
T
T
Eto
T
T
Omae
D000310:Adrenal Gland Neoplasms / Q000097:blood / Q000378:metabolism / Q000503:physiopathology*; D000313:Adrenal Medulla / Q000378:metabolism; D053607:Adrenomedullin; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents; D001794:Blood Pressure; D004837:Epinephrine / Q000097:blood; D005260:Female; D015870:Gene Expression; D006339:Heart Rate; D006352:Heart Ventricles; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000378:metabolism / Q000503:physiopathology*; D007668:Kidney / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000378:metabolism / Q000503:physiopathology*; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000097:blood; D010452:Peptide Biosynthesis; D010455:Peptides / Q000097:blood*; D010673:Pheochromocytoma / Q000097:blood / Q000378:metabolism / Q000503:physiopathology*; D011651:Pulmonary Artery / Q000503:physiopathology; D011652:Pulmonary Circulation; D012333:RNA, Messenger / Q000096:biosynthesis
D000959:Antihypertensive Agents; D010455:Peptides; D012333:RNA, Messenger; D053607:Adrenomedullin; D009638:Norepinephrine; D004837:Epinephrine